| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |